✦ LIBER ✦

Comparison of combination therapies in the treatment of rheumatoid arthritis: leflunomide-anti-TNF-alpha versus methotrexate-anti-TNF-alpha

✍ Scribed by Renato De Stefano; Elena Frati; Fernando Nargi; Caterina Baldi; Luana Menza; Mohammed Hammoud; Mauro Galeazzi

Publisher: Springer
Year: 2010
Tongue: English
Weight: 194 KB
Volume: 29
Category: Article
ISSN: 0770-3198
DOI: 10.1007/s10067-009-1349-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical evaluation of tocilizumab for p

Clinical evaluation of tocilizumab for patients with active rheumatoid arthritis refractory to anti-TNF biologics: tocilizumab in combination with methotrexate

✍ Yasuharu Nakashima; Masakazu Kondo; Hiroshi Harada; Takahiko Horiuchi; Takashi I 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 348 KB

Combination therapy with cyclosporine A

Combination therapy with cyclosporine A and anti-TNF-α agents in the treatment of rheumatoid arthritis and concomitant hepatitis C virus infection

✍ Francesca Bellisai; Chiara Giannitti; Alessandro Donvito; Mauro Galeazzi 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 76 KB

Should anti-TNF therapy be discontinued

Should anti-TNF therapy be discontinued in rheumatoid arthritis patients undergoing elective orthopaedic surgery? A systematic review of the evidence

✍ Leslie Goh; Teresa Jewell; Catherine Laversuch; Ash Samanta 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 273 KB

Unravelling the phenotype of cardiovascu

Unravelling the phenotype of cardiovascular inflammation with magnetic resonance imaging: detecting the change with anti-TNF treatment in patients with rheumatoid arthritis

✍ Valentina O Puntmann; Peter Taylor; Rolf Gebker; Bernhard Schnackenburg; Amedeo 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 489 KB

To investigate the phenotypic relationships between aortic stiffness and left ventricular (LV) modes of deformation in patients with rheumatoid arthritis (RA) with anti-TNF therapy.

Cost-effectiveness modeling of abatacept

Cost-effectiveness modeling of abatacept versus other biologic agents in DMARDS and anti-TNF inadequate responders for the management of moderate to severe rheumatoid arthritis

✍ Anthony Russell; Ariel Beresniak; Louis Bessette; Boulos Haraoui; Proton Rahman; 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 183 KB

Outcomes of switching anti-TNF drugs in

Outcomes of switching anti-TNF drugs in rheumatoid arthritis—a study based on observational data from the Finnish Register of Biological Treatment (ROB-FIN)

✍ Liisa M. Virkki; Heikki Valleala; Yuya Takakubo; Jorma Vuotila; Heikki Relas; Ri 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 281 KB